INDP (STOCKS)
Indaptus Therapeutics, Inc. Common Stock
$3.620000
+0.040000 (+1.12%)
Prev close: $3.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jun Yi Dai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $417.86M
- Employees
- 7
- P/E (TTM)
- -0.23
- P/B (TTM)
- 324.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-4.51 | $-4.45 | -0.0628 | -1.41% |
|
Sep 2025 (Q3)
|
$-2.98 | $-4.25 | +1.2734 | +29.94% |
|
Jun 2025 (Q2)
|
$-9.09 | $-9.42 | +0.3348 | +3.55% |
|
Mar 2025 (Q1)
|
$-8.96 | $-5.14 | -3.8192 | -74.29% |
Financial Statements
| Assets | $2.18M |
| Current Assets | $2.18M |
| Noncurrent Assets | $0.00 |
| Liabilities | $933.00K |
| Current Liabilities | $933.00K |
| Accounts Payable | $557.37K |
| Wages | $43.08K |
| Other Current Liabilities | $332.56K |
| Noncurrent Liabilities | $0.00 |
| Equity | $1.25M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.25M |
| Liabilities And Equity | $2.18M |